Enzo Biochem Inc - Company Profile

Powered by

All the data and insights you need on Enzo Biochem Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Enzo Biochem Inc Strategy Report

  • Understand Enzo Biochem Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Enzo Biochem Inc (Enzo Biochem) is a life sciences and biotechnology company which focuses on harnessing genetic processes for the development of research tools, therapeutics, and diagnostics. It also provides reference laboratory services to the medical community. The company focuses on the development of enabling technologies in the fields of gene regulation and modification. Enzo Biochem’s technologies find application in the pharmaceutical and biomedical research markets. The company’s gene analysis has led to the development of several major therapeutic candidates for the treatment of viral and immunological disorders. The company operates in the US, Switzerland, Benelux, Germany, France, and the UK. Enzo Biochem is headquartered in New York, the US.

Gain a 360-degree view of Enzo Biochem Inc and make more informed decisions for your business Gain a 360-degree view of Enzo Biochem Inc and make more informed decisions for your business Find out more
Headquarters United States of America

Address 60 Executive Blvd, Farmingdale, New York, 11735


Telephone 1 516 7555500

No of Employees 179

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange ENZ (NYSE)

Revenue (2022) $31.1M -4.8% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ 211.1% (2022 vs 2021)

Market Cap* $56.9M

Net Profit Margin (2022) XYZ 216.8% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Enzo Biochem Inc premium industry data and analytics

13+

Pipeline Drugs

Identify which of Enzo Biochem Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

12+

Clinical Trials

Determine Enzo Biochem Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Enzo Biochem Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
Antibodies Genomics Analysis Alequel
Assays and Kits Optiquel
Biochemicals Enzo
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Enzo Biochem Inc portfolio and identify potential areas for collaboration Understand Enzo Biochem Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 New Products/Services In September, the company launched Ampiview Gene Expression Platform.
2021 Regulatory Approval In July, the company received an Emergency Use Authorization from the US FDA for its proprietary test system for detection of COVID-19 virus.
2021 Contracts/Agreements In June, the company collaborated with CLX Health to provide online services for COVID-19 PCR testing through TrustAssure Global Network platform.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Enzo Biochem Inc Revvity Inc RadNet Inc Ionis Pharmaceuticals Inc Avadim Health Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Farmingdale Waltham Los Angeles Carlsbad Asheville
State/Province New York Massachusetts California California North Carolina
No. of Employees 179 11,500 7,872 927 226
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Kara Cannon Chief Operating Officer; Chief Executive Officer - Interim Senior Management 2023 -
Patricia Eckert Chief Financial Officer - Interim Senior Management 2022 -
Barry W. Weiner President Senior Management 1996 71
Matthew Kupferberg General Counsel Senior Management 2022 -
Mary Tagliaferri Director Non Executive Board 2020 55
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Enzo Biochem Inc key executives to enhance your sales strategy Gain insight into Enzo Biochem Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer